BofA/Merrill Lynch Upgrades Pacira Pharmaceuticals (PCRX) to Neutral (Earlier)

July 31, 2015 9:48 AM

BofA/Merrill Lynch earlier upgraded Pacira Pharmaceuticals (NASDAQ: PCRX) from Underperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found